A nationwide population-based cross-sectional survey of health-related quality of life in patients with myeloproliferative neoplasms in Denmark (MPNhealthSurvey): survey design and characteristics of respondents and nonrespondents

被引:8
作者
Brochmann, Nana [1 ]
Flachs, Esben Meulengracht [2 ]
Christensen, Anne Illemann [3 ]
Andersen, Christen Lykkegaard [1 ]
Juel, Knud [3 ]
Hasselbalch, Hans Carl [1 ]
Zwisler, Ann-Dorthe [4 ,5 ]
机构
[1] Univ Copenhagen, Zealand Univ Hosp, Dept Hematol, Vestermarksvej 9, DK-4000 Roskilde, Denmark
[2] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark
[3] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark
[4] Univ Southern Denmark, Danish Knowledge Ctr Rehabil & Palliat Care, Odense, Denmark
[5] Odense Univ Hosp, Odense, Denmark
关键词
survey design; cross-sectional survey; nationwide survey; patient-reported outcomes; health-related quality of life; myeloproliferative neoplasms; CHRONIC MYELOID-LEUKEMIA; POLYCYTHEMIA-VERA; SYMPTOM BURDEN; THERAPY; FATIGUE; DISEASE; IMPACT; RUXOLITINIB; IMATINIB; MYELOFIBROSIS;
D O I
10.2147/CLEP.S117587
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: The Department of Hematology, Zealand University Hospital, Denmark, and the National Institute of Public Health, University of Southern Denmark, created the first nationwide, population-based, and the most comprehensive cross-sectional health-related quality of life (HRQoL) survey of patients with myeloproliferative neoplasms (MPNs). In Denmark, all MPN patients are treated in public hospitals and treatments received are free of charge for these patients. Therefore, MPN patients receive the best available treatment to the extent of its suitability for them and if they wish to receive the treatment. The aims of this article are to describe the survey design and the characteristics of respondents and nonrespondents. Material and methods: Individuals with MPN diagnoses registered in the Danish National Patient Register (NPR) were invited to participate. The registers of the Danish Civil Registration System and Statistics Denmark provided information regarding demographics. The survey contained 120 questions: validated patient-reported outcome (PRO) questionnaires and additional questions addressing lifestyle. Results: A total of 4,704 individuals were registered with MPN diagnoses in the NPR of whom 4,236 were eligible for participation and 2,613 (62%) responded. Overall, the respondents covered the broad spectrum of MPN patients, but patients 70-79 years old, living with someone, of a Danish/Western ethnicity, and with a higher level of education exhibited the highest response rate. Conclusion: A nationwide, population-based, and comprehensive HRQoL survey of MPN patients in Denmark was undertaken (MPNhealthSurvey). We believe that the respondents broadly represent the MPN population in Denmark. However, the differences between respondents and nonrespondents have to be taken into consideration when examining PROs from the respondents. The results of the investigation of the respondents' HRQoL in this survey will follow in future articles.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 55 条
[1]   Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms [J].
Abelsson, Johanna ;
Andreasson, Bjorn ;
Samuelsson, Jan ;
Hultcrantz, Malin ;
Ejerblad, Elisabeth ;
Johansson, Berit ;
Emanuel, Robyn ;
Mesa, Ruben ;
Johansson, Peter .
LEUKEMIA & LYMPHOMA, 2013, 54 (10) :2226-2230
[2]   Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls [J].
Anderson, Lesley A. ;
James, Glen ;
Duncombe, Andrew S. ;
Mesa, Ruben ;
Scherber, Robyn ;
Dueck, Amylou C. ;
de Vocht, Frank ;
Clarke, Mike ;
McMullin, Mary F. .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) :864-870
[3]   Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet [J].
Barbui, Tiziano ;
Barosi, Giovanni ;
Birgegard, Gunnar ;
Cervantes, Francisco ;
Finazzi, Guido ;
Griesshammer, Martin ;
Harrison, Claire ;
Hasselbalch, Hans Carl ;
Hehlmann, Rudiger ;
Hoffman, Ronald ;
Kiladjian, Jean-Jacques ;
Kroeger, Nicolaus ;
Mesa, Ruben ;
McMullin, Mary F. ;
Pardanani, Animesh ;
Passamonti, Francesco ;
Vannucchi, Alessandro M. ;
Reiter, Andreas ;
Silver, Richard T. ;
Verstovsek, Srdan ;
Tefferi, Ayalew .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) :761-770
[4]   Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis [J].
Barosi, Giovanni ;
Rosti, Vittorio ;
Bonetti, Elisa ;
Campanelli, Rita ;
Carolei, Adriana ;
Catarsi, Paolo ;
Isgro, Antonina M. ;
Lupo, Letizia ;
Massa, Margherita ;
Poletto, Valentina ;
Viarengo, Gianluca ;
Villani, Laura ;
Magrini, Umberto .
PLOS ONE, 2012, 7 (04)
[5]   Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008 [J].
Bjorkholm, Magnus ;
Ohm, Lotta ;
Eloranta, Sandra ;
Derolf, Asa ;
Hultcrantz, Malin ;
Sjoberg, Jan ;
Andersson, Therese ;
Hoglund, Martin ;
Richter, Johan ;
Landgren, Ola ;
Kristinsson, Sigurdur Y. ;
Dickman, Paul W. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) :2514-2520
[6]   Mechanisms of disease: The myeloproliferative disorders [J].
Campbell, Peter J. ;
Green, Anthony R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2452-2466
[7]   The Impact of Symptom Burden on Patient Quality of Life in Chronic Myeloid Leukemia [J].
Cella, David ;
Nowinski, Cindy J. ;
Frankfurt, Olga .
ONCOLOGY, 2014, 87 (03) :133-147
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   The Danish National Health Survey 2010. Study design and respondent characteristics [J].
Christensen, Anne Illemann ;
Ekholm, Ola ;
Glumer, Charlotte ;
Andreasen, Anne Helms ;
Hvidberg, Michael Falk ;
Kristensen, Peter Lund ;
Larsen, Finn Breinholt ;
Ortiz, Britta ;
Juel, Knud .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2012, 40 (04) :391-397
[10]   Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib [J].
Efficace, F. ;
Baccarani, M. ;
Breccia, M. ;
Cottone, F. ;
Alimena, G. ;
Deliliers, G. L. ;
Barate, C. ;
Specchia, G. ;
Di Lorenzo, R. ;
Luciano, L. ;
Turri, D. ;
Martino, B. ;
Stagno, F. ;
Dabusti, M. ;
Bergamaschi, M. ;
Leoni, P. ;
Simula, M. P. ;
Levato, L. ;
Fava, C. ;
Veneri, D. ;
Sica, S. ;
Rambaldi, A. ;
Rosti, G. ;
Vignetti, M. ;
Mandelli, F. .
LEUKEMIA, 2013, 27 (07) :1511-1519